News

CymaBay to Report First Quarter 2017 Financial Results on Thursday, May 11

NEWARK, Calif., May 04, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases with high unmet medical need, today announced that it will host a conference call and live audio webcast on Thursday, May 11th at 4:30 p.m. Eastern Time to discuss financial results for the first quarter ended March 31, 2017 and provide a business update.

2017-06-27T12:13:57+00:00